Gunnar Nilsson's Cancer Foundation - Board of directors

Gunnar Nilsson's Cancer Foundation - Board of directors

Mef Nilbert, MD, Professor

Anders Bjartell MD, Professor

Martin Malmberg, MD, PhD, Consultant

Christer Arnbäck, financial expert

Johan Richter, MD, Associate Professor

Kjell Stenström, lawyer

Mef Nilbert, MD, Professor, born 1967, chairman of the board.
Mef Nilbert is one of the board members in the field of medicine and works at the Department of Oncology at the University Hospital in Lund. After a research fellowship at the genetic clinic and at the Johns Hopkins Hospital in Baltimore, USA, she defended her thesis in experimental clinical genetics in 1991 on chromosome changes in muscle tumours. Mef Nilbert became a senior lecturer in experimental oncology in 1999 and professor in oncology 2005. She works with tumour biological and prognostic studies of colorectal cancer and sarcoma and with patients with hereditary cancer. Mef Nilbert also works with evaluation of grant applications for several cancer research funds/foundations and also leads a research group of 8 doctors/researchers and has approx. 90 scientific publications.

Professor Dick Killander, MD, born 1937.
Dick Killander is, since the beginning, chairman of the board.
   Disputation and senior lectureship at the Institute for Medical Cell research and genetics, the Medical Nobel Institute, the Karolinska Institute, Stockholm. Clinical work in various positions at the Radium home, Karolinska hospital 1969 to 1977. Thereafter professor and consultant at the Department of Oncology, University hospital in Lund. Emeritus since 2004.
  Scientific publications (approx 125) within cell and tumour biology and clinical oncology. Dick Killander has, amongst various assignments, also been a member of the Cancer Foundation’s board and research committee, the Fernström Foundation’s prize committee and the grant committee and ethical research committee at the Medical faculty in Lund.
  Assignments as board member include at present also Berta Kamprad's Cancer Foundation, John and Augusta Persson’s Cancer Foundation and the foundation Lydiagården (cancer rehabilitation).

Martin Malmberg, MD, PhD, born 1952 is one of the board members in the field of medicine and became, after studies at Lund University and training in Helsingborg, specialist in general surgery 1984. After experimental oncology research at Roswell Park Cancer Institute in Buffalo, USA, he defended his thesis Assessement of cell heterogeneity in drug response at Lund University in 1993. Dr. Malmberg has been a consultant in surgery at Helsingborg hospital since 1989 and has initiated and been responsible for the oncology treatment unit at the hospital. Since 2005 Dr. Malmberg is consultant at the department of oncology at the University Hospital in Lund but still responsible for the oncology treatment unit in Helsingborg. Dr. Malmberg´s main clinical interest has been the treatment of breast cancer and clinical trials in oncology where he has participated actively.
Dr. Malmberg has authored or co-authored 17 peer-reviewed publications and 51 abstracts in the field of oncology, is chairman for the regional oncology board, board member for The Oncological Society of Southern Sweden, and is a member of the Swedish Society of Oncology, American Society for Clinical Oncology (ASCO) and American Association for Cancer Research (AACR).

Christer Arnbäck, born in Malmö, Sweden, 1942, Geneva, Switzerland.
Christer Arnbäck is the board’s financial expert and manages the foundation’s share portfolio, buys and sells shares, bonds and other securities and makes sure that the capital yields the best interest. Christer Arnbäck, who lives in Switzerland, is fluent in French, English, Swedish and German and has some knowledge of Italian, Spanish and Scandinavian languages. He attended university both in Sweden and in Switzerland, where, at the University of Geneva, he got his Master’s degree in Economics and Law in 1968.The topic of his thesis was Geneva banking systems, Investment funds. In 1988 Christer Arnbäck founded Arnbäck & Co. SA, Geneva, an Investment Management & Financial Services Company, member of the Swiss Stock Exchanges. Christer Arnbäck is also on the board of numerous Swiss and international companies. Thus, Christer Arnbäck has an extensive international network of contacts after more than 35 years of experience in the field of investment and financial services. He has specialised in investments, tax questions, double taxation agreements, establishments and immigration and emigration matters. Christer Arnbäck knew Gunnar Nilsson personally and helped him with financial questions in connection with his international career. Christer Arnbäck was elected board member in 1991.

Clas-Ebbe Lindholm, MD, Consultant, born 1937.
Lindholm is one of board members in the field of medicine. He began his medical studies in 1958 and graduated as Licentiate of Medicine 1968 and became a fully qualified doctor.
He has worked as assistant physician at clinics for X-ray, anaesthesia, surgery, medicine and radio therapy. In 1973 Lindholm got his specialist degree in general oncology and then worked as assistant physician, amanuensis and assistant consultant at the Department of Oncology at the University hospital in Malmö until 1986 when he was appointed consultant at that clinic 1987.
1992 Lindholm became MD after defending his thesis in medical science, titled “Hyperthermia and Radiotherapy. A study on malignant superficial tumours”.
Lindholm, who has been a board member from the start, is a member of the Swedish Oncological Society, the Swedish Society for Urological Oncology and the Swedish Medical Society.

Johan Richter, senior lecturer, consultant, born 1955, is currently working at the Department of Molecular Medicine and Gene Therapy, Lund’s University and the Department of Hematology, University Hospital in Lund. Johan Richter studied medicine at Lund University and the University of California, San Francisco. After research studies at the Department for Hematology in Lund he defended his thesis
(”Cytokine-induced degranulation in human neutrophils - role of leukocyte adhesion molecules and cytosolic free calcium”) in 1991. From 1995 to 1996 he worked at the National Institutes of Health, Bethesda, USA and after that he took an active part in establishing the Department of Molecular Medicine and Gene Therapy at Lund University. Johan Richter’s research is focused on blood forming stem cells and the possibility to develop gene therapy aimed at diseases affecting blood and bone marrow.

Kjell Stenström, lawyer, born 1940.
Kjell Stenström is the foundation's secretary and is responsible for the day-to-day administration. Kjell Stenström got his law degree in Lund and after a short period of training in Malmö to become a notary, he worked as ombudsman for one year at the real estate owners’ society in Helsingborg. In 1973 Kjell Stenström started working as an assistant counsel at a law firm in Helsingborg. In 1977 Kjell Stenström became a member of the Bar Association and has until 2003 been working as a lawyer in Helsingborg. He then moved to France where he continued his work as a lawyer on a smaller scale. He is a member of the French Bar Association.
He has had a strong commitment to the Swedish Bar Association’s different branches and has, amongst other things, been chairman of the Bar Association’s southern division and its work council. Kjell became acquainted with Gunnar during his period as ombudsman for the real estate owner’s society in Helsingborg. Later he was Gunnar’s legal representative during his entire career in motor sport and represented Gunnar and Elisabeth Nilsson at the founding of various foundations, both Swedish and foreign, for cancer research. Thus, Kjell Stenström has been a member of the foundation’s board since it was started.

Gunnar Nilsson's Cancer Foundation is supervised by the County Board and the collection of donations is controlled by the Foundation for collection control (SFI).